Patients with coronary artery disease (CAD) need systemic management in addition to coronary revascularization to improve clinical outcomes. Many studies and guidelines have shown that evidence-based use of optimal medical therapy (OMT), which consists of an antiplatelet agent, β blocker, statin, and angiotensin-converting enzyme (ACE) inhibitor or angiotensin receptor blocker (ARB), is an essential treatment for patients with CAD, including patients who have undergone coronary artery bypass grafting (CABG).
1 x 1 Smith, S.C. Jr, Benjamin, E.J., Bonow, R.O., Braun, L.T., Creager, M.A., Franklin, B.A., Gibbons, R.J., Grundy, S.M., Hiratzka, L.F., Jones, D.W., Lloyd-Jones, D.M., Minissian, M., Mosca, L., Peterson, E.D., Sacco, R.L., Spertus, J., Stein, J.H., Taubert, K.A., and World Heart Federation, the Preventive Cardiovascular Nurses Association. AHA/ACCF secondary prevention and risk reduction therapy for patients with coronary and other atherosclerotic vascular disease: 2011 update: a guideline from the American Heart Association and American College of Cardiology Foundation. Circulation. 2011; 124: 2458–2473 Crossref | PubMed | Scopus (720) | Google Scholar See all References
, 2 x 2 Kulik, A., Ruel, M., Jneid, H., Ferguson, T.B., Hiratzka, L.F., Ikonomidis, J.S., Lopez-Jimenez, F., McNallan, S.M., Patel, M., Roger, V.L., Sellke, F.W., Sica, D.A., Zimmerman, L., and American Heart Association Council on Cardiovascular and Stroke Nursing, Anesthesia. Secondary prevention after coronary artery bypass graft surgery: a scientific statement from the American Heart Association. Circulation. 2015; 131: 927–964 Crossref | PubMed | Scopus (66) | Google Scholar See all References We have shown the limited efficacy of percutaneous coronary intervention (PCI) in post-CABG patients as a secondary revascularization because the effect of PCI is dependent on preprocedural coronary atherosclerosis.
3 x 3 Miyagi, T., Asaumi, Y., Nishimura, K., Nakashima, T., Sakamoto, H., Nakao, K., Kanaya, T., Nagai, T., Shimabukuro, Y., Miyamoto, Y., Fujita, T., Kusano, K., Anzai, T., Kobayashi, J., Noguchi, T., Ogawa, H., and Yasuda, S. Validation of the Coronary Artery Bypass Graft SYNTAX Score (synergy between percutaneous coronary intervention with taxus) as a prognostic marker for patients with previous coronary artery bypass graft surgery after percutaneous coronary intervention. Circ Cardiovasc Interv. 2016; 9 (e003459) Crossref | PubMed | Scopus (2) | Google Scholar See all References Because post-CABG patients requiring secondary revascularization long after initial CABG have advanced coronary atherosclerosis, the efficacy of these medications in this patient population remains unclear. Thus, we sought to examine the effect of OMT and its components on patients with previous CABG who underwent secondary PCI.